Claus Runge leads the Market Access, Public Affairs & Sustainability group at Bayer AG – Pharmaceuticals. Claus is a pharmacist and health economist by training and holds a Ph.D. from the Humboldt University in Berlin. He served as one of the editors of the European Journal of Health Economics from 2006-2017, and has published numerous articles in high impact journals, with a focus on health economics and quality of life research.
The COVID-19 pandemic is already disrupting sexual and reproductive health and rights globally. Representatives from Bayer and UNFPA highlight the need to ensure access to contraceptives both during and after the pandemic — or else risk devastating consequences for many women.